Chemical Financial Corporation reports fourth quarter 2017 net income of $9.4 million, representing $0.13 of earnings per diluted average share

MIDLAND, Mich., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Chemical Financial Corporation ("Corporation" or "Chemical") (NASDAQ:CHFC) today announced 2017 fourth quarter net income of $9.4 million, or $0.13 per diluted share, compared to 2017 third quarter net income of $40.5 million, or $0.56 per diluted share, and 2016 fourth quarter net income of $47.2 million, or $0.66 per diluted share. For the year ended December 31, 2017, net income was $149.5 million, or $2.08 per diluted share, compared to net income for the year ended December 31, 2016 of $108.0 million, or $2.17 per diluted share. Net income, excluding significant items, a non-GAAP financial measure, which excludes the fourth quarter of 2017 charge to income tax expense of $46.7 million resulting from the revaluation of Corporation's net deferred tax assets completed following the signing of the Tax Cuts and Jobs Act in December 2017, merger and restructuring expenses of $2.6 million and fourth quarter of 2017 losses of $7.6 million on sales of investment securities as part of the Corporation's treasury and tax management objectives (which we collectively refer to herein as "significant items"), was $62.7 million, or $0.87 per diluted share, in the fourth quarter of 2017.(1) Third quarter of 2017 net income, excluding significant items (merger and restructuring expenses of $21.2 million) was $54.2 million, or $0.76 per diluted share, and fourth quarter of 2016 net income, excluding significant items (merger expenses of $18.0 million and a $7.4 million net gain on the sale of branches) was $54.1 million, or $0.75 per diluted share.(1) Net income for the full year 2017, excluding significant items was $219.6 million, or $3.06 per diluted share, compared to $143.7 million, or $2.88 per diluted share for the full year 2016.(1) In addition, on January 23, 2018, the Board of Directors of the Corporation declared a first quarter of 2018 dividend on its common stock of $0.28 per share. The first quarter of 2018 dividend will be payable on March 16, 2018, to shareholders of record on March 2, 2018.

"We are pleased with our results for the quarter, including improved efficiency resulting from our restructuring efforts, high quality loan growth, maintaining a stable net interest margin and making headway on new commercial banker hires," noted David T. Provost, Chief Executive Officer of the Corporation and Thomas C. Shafer, Vice Chairman of the Corporation and Chief Executive Office of Chemical Bank. "We believe the efforts that we have undergone put us in a solid position for a successful 2018. We look forward to further growth in our markets to be achieved through investments in expanding our commercial lending and banking teams in high growth areas, key operation staff adds to support our customer service enhancements and enhancing our core systems."

The Corporation's return on average assets was 0.20% during the fourth quarter of 2017, compared to 0.86% in the third quarter of 2017, and 1.09% in the fourth quarter of 2016. The Corporation's return on average shareholders' equity was 1.4% in the fourth quarter of 2017, compared to 6.1% in the third quarter of 2017, and 7.4% in the fourth quarter of 2016. The Corporation's return on average assets, excluding significant items, a non-GAAP financial measure, was 1.31% in the fourth quarter of 2017, compared to 1.15% in the third quarter of 2017, and 1.25% in the fourth quarter of 2016.(1) The Corporation's return on average shareholders' equity, excluding significant items, a non-GAAP financial measure, was 9.4% in the fourth quarter of 2017, compared to 8.2% in the third quarter of 2017, and 8.4% in the fourth quarter of 2016.(1) The Corporation's return on average tangible shareholders' equity was 2.5% in the fourth quarter of 2017, compared to 10.9% in the third quarter of 2017, and 13.4% in the fourth quarter of 2016. The Corporation's return on average tangible equity, excluding significant items, a non-GAAP financial measure, was 16.5% in the fourth quarter of 2017, compared to 14.6% during the third quarter of 2017, and 15.3% in the fourth quarter of 2016.(1)

Net interest income was $145.9 million in the fourth quarter of 2017, $2.3 million, or 1.6%, higher than the third quarter of 2017, and $13.5 million, or 10.2%, higher than the fourth quarter of 2016. The higher net interest income in the fourth quarter of 2017, compared to both the third quarter of 2017 and the fourth quarter of 2016 was primarily attributable to increases in average loans and investment securities. The Corporation experienced net loan growth of $321.9 million during the fourth quarter of 2017 and $1.16 billion during the year ended December 31, 2017.

The net interest margin was 3.39% in the fourth quarter of 2017, compared to 3.40% in the third quarter of 2017 and 3.48% in the fourth quarter of 2016. The net interest margin, on a tax-equivalent basis, a non-GAAP financial measure, was 3.47% in the fourth quarter of 2017, compared to 3.48% in the third quarter of 2017, and 3.56% in the fourth quarter of 2016.(1) The average yield on the loan portfolio was 4.31% in both the fourth and third quarters of 2017, compared to 4.18% in the fourth quarter of 2016. Interest accretion from purchase accounting discounts on acquired loans contributed 22 basis points to the Corporation's net interest margin, on a tax-equivalent basis, in the fourth quarter of 2017, compared to 23 basis points in the third quarter of 2017, and 14 basis points in the fourth quarter of 2016. The Corporation's average cost of funds was 0.56% in the fourth quarter of 2017, compared to 0.53% in the third quarter of 2017, and 0.33% in the fourth quarter of 2016.

Net interest income was $557.6 million for the year ended December 31, 2017, $176.5 million, or 46.3%, higher than the year ended December 31, 2016. The average balance of loans outstanding during the year ended December 31, 2017 were up $4.30 billion compared to the prior year, with the increase driven by $4.88 billion of loans added on August 31, 2016 from the Corporation's merger with Talmer Bancorp Inc. ("Talmer"), and $1.16 billion of originated loan growth during 2017. The net interest margin was 3.40% in 2017 and 3.51% in 2016. The net interest margin, on a tax equivalent basis, a non-GAAP financial measure, was 3.48% in 2017, compared to 3.60% in 2016.(1)

The provision for loan losses was $7.5 million in the fourth quarter of 2017, compared to $5.5 million in the third quarter of 2017 and $6.3 million in the fourth quarter of 2016. The increase in the provision for loan losses in the fourth quarter of 2017, compared to the third quarter of 2017 and the fourth quarter of 2016, was primarily the result of an increase in originated loan growth. The provision for loan losses was $23.3 million for the year ended December 31, 2017, compared to $14.9 million for the year ended December 31, 2016, with the increase primarily due to an increase in originated loan growth. All acquired loans were recorded at their estimated fair value at each respective acquisition date without a carryover of the related allowance and, as of December 31, 2017, no allowance was determined to be needed for this population of loans.

Net loan charge-offs were $1.4 million, or 0.04% of average loans, in the fourth quarter of 2017, compared to $3.5 million, or 0.10% of average loans, in the third quarter of 2017 and $1.8 million, or 0.06% of average loans, in the fourth quarter of 2016. The decrease in net loan charge-offs in the fourth quarter of 2017, compared to the third quarter of 2017, was primarily due to one commercial loan relationship charge-off in the third quarter of 2017 and an increase in recoveries on commercial real estate loans in the fourth quarter of 2017. The decrease in net loan charge-offs in the fourth quarter of 2017, compared to the fourth quarter of 2016, was primarily attributable to an increase in net recoveries on commercial real estate loans in the fourth quarter of 2017. Net loan charge-offs totaled $9.7 million, or 0.07% of average loans, during the year ended December 31, 2017, compared to $9.9 million, or 0.11% of average loans, during the year ended December 31, 2016.

The Corporation's nonperforming loans totaled $63.1 million at December 31, 2017, compared to $54.3 million at September 30, 2017 and $44.3 million at December 31, 2016. Nonperforming loans comprised 0.45% of total loans at December 31, 2017, compared to 0.39% at September 30, 2017, and 0.34% at December 31, 2016. The increase in nonperforming loans as a percentage of total loans at December 31, 2017, compared to December 31, 2016, was primarily due to previously accruing commercial troubled debt restructurings downgraded to nonaccrual status.

The allowance for loan losses for the originated loan portfolio was $91.9 million, or 0.94% of originated loans at December 31, 2017, compared to $85.2 million, or 0.93% of originated loans, at September 30, 2017 and $78.3 million, or 1.05% of originated loans, at December 31, 2016. The increase in the allowance for loan losses for the originated portfolio reflects organic growth in the loan portfolio and an increase in the allowance coverage needed for loans that are individually evaluated for impairment. The allowance for loan losses for the originated loan portfolio as a percentage of nonperforming loans was 145.6% at December 31, 2017, compared to 156.9% at September 30, 2017, and 176.5% at December 31, 2016. The third quarter of 2017 allowance for loan losses for the acquired loan portfolio of $0.6 million was reversed during the fourth quarter of 2017, due to improvement identified in the quarterly re-estimation of cash flows.

Noninterest income was $32.3 million in the fourth quarter of 2017, compared to $32.1 million in the third quarter of 2017, and $54.3 million in the fourth quarter of 2016. Noninterest income in the fourth quarter of 2017 was slightly higher than the third quarter of 2017, primarily due to increases in net gain on sale of loans and other mortgage banking revenue and interest rate swap fee income, included within other income, partially offset by $7.6 million of losses on sale of investment securities incurred in the fourth quarter of 2017, as part of the Corporation's treasury and tax management objectives. Noninterest income in the fourth quarter of 2017 was lower than the fourth quarter of 2016 primarily due to the losses on sales of investment securities recognized in the fourth quarter of 2017, a decrease in net gain on sale of loans and other mortgage banking revenue, and the fourth quarter of 2016 gain on sale of branches. Net gain on sale of loans and other mortgage banking revenue included a $13 thousand detriment to earnings due to a change in fair value in loan servicing rights in the fourth quarter of 2017, compared to a $4.0 million detriment in the third quarter of 2017, and a benefit of $6.3 million in the fourth quarter of 2016. Noninterest income was $144.0 million for the year ended December 31, 2017, compared to $122.4 million in 2016, which increased primarily due to incremental revenue resulting from the merger with Talmer.

Operating expenses were $100.0 million in the fourth quarter of 2017, compared to $119.5 million in the third quarter of 2017, and $114.3 million in the fourth quarter of 2016. Operating expenses included merger and restructuring expenses of $2.6 million in the fourth quarter of 2017, $21.2 million in the third quarter of 2017, and $18.0 million in the fourth quarter of 2016. Fourth quarter of 2017 included $6.2 million of impairment related to federal historic tax credits placed into service during the quarter, included within other operating expense, compared to $3.1 million in the third quarter of 2017. Core operating expenses, a non-GAAP financial measure, which excludes merger and restructuring expenses and the impairment of federal historic tax credits, were $91.3 million in the fourth quarter of 2017, a decrease of $3.9 million, compared to $95.2 million in the third quarter of 2017, primarily due to the impact of the Corporation's restructuring efforts that began in the third quarter of 2017.(1)

Operating expenses were $422.0 million for the year ended December 31, 2017, compared to $338.4 million in 2016. Operating expenses included merger and restructuring expenses of $28.4 million in 2017 and $61.1 million in 2016. The year ended December 31, 2017 also included $9.3 million of impairment related to federal historic tax credits placed into service, included within other operating expenses. Core operating expenses, a non-GAAP financial measure, which excludes merger and restructuring expenses and the impairment of federal historic tax credits, were $384.3 million in 2017, compared to $277.3 million in 2016, with the increase due primarily to incremental expenses resulting from the merger with Talmer.(1)

The Corporation's effective tax rate was 86.6% in the fourth quarter of 2017, compared to 20.2% in the third quarter of 2017 and 28.7% in the fourth quarter of 2016. The tax rate for the fourth quarter of 2017 was impacted by the $46.7 million charge to income tax expense as a result of the revaluation of Corporation's net deferred tax assets and the benefit of federal historic tax credits placed into service during the quarter. The tax rate for the third quarter of 2017 benefited from a federal historic tax credit placed into service during the quarter. The income tax benefit from the tax credits placed into service were partially offset by the impairment recorded on the same tax credits included within other operating expenses. The effective tax rate for the year ended December 31, 2017 was 41.7%, compared to 28.0% for 2016. Excluding the impact of the revaluation of net deferred tax assets in the fourth quarter of 2017 and the benefit of federal historic tax credits placed into service, the effective tax rate for the year ended December 31, 2017 was 27.1%.

The efficiency ratio is a measure of operating expenses as a percentage of net interest income and noninterest income. The Corporation's efficiency ratio was 56.1% in the fourth quarter of 2017, 68.0% in the third quarter of 2017, and 61.2% in the fourth quarter of 2016. The Corporation's efficiency ratio was 60.1% for the year ended December 31, 2017 and 67.2% for 2016. The Corporation's adjusted efficiency ratio, a non-GAAP financial measure, which excludes significant items, amortization of intangibles, impairment of income tax credits, the net interest income FTE adjustment, the change in fair value on loan servicing rights, and losses/gains from sale of investment securities and closed branch locations, was 47.4% in the fourth quarter of 2017, 51.2% in the third quarter of 2017 and 53.7% in the fourth quarter of 2016. The Corporation's adjusted efficiency ratio was 51.9% for the year ended December 31, 2017 and 54.4% for 2016.(1)

Total assets were $19.28 billion at December 31, 2017, compared to $19.35 billion at September 30, 2017, and $17.36 billion at December 31, 2016. The decrease in total assets during the fourth quarter of 2017 was primarily attributable to a decrease in interest-bearing deposits with the Federal Reserve Bank and a reduction in net deferred tax assets, included within interest receivable and other assets, as a result of the revaluation of the net deferred tax assets, partially offset by loan growth.

Total loans were $14.16 billion at December 31, 2017, up $321.9 million, or 2.3%, from total loans of $13.83 billion at September 30, 2017, and up $1.16 billion, or 9.0%, from total loans of $12.99 billion at December 31, 2016. Originated loan growth was $591.3 million in the fourth quarter of 2017, compared to $496.5 million in the third quarter of 2017, and $702.5 million in the fourth quarter of 2016. The growth in the originated loan portfolio was partially offset by run-off in the acquired loan portfolio of $269.4 million in the fourth quarter of 2017, compared to $330.5 million in the third quarter of 2017, and $427.5 million in the fourth quarter of 2016.

Investment securities available-for-sale were $1.96 billion at December 31, 2017, a decrease of $66.1 million, from $2.03 billion at September 30, 2017. The decrease was primarily the result of the sale of approximately $400 million of securities in a loss position sold late in the fourth quarter of 2017 as part of treasury and tax management objectives set into place associated with the passing the Tax Cuts and Jobs Act in December of 2017, partially offset by reinvesting a portion of the proceeds in new securities prior to year end. The sale of these securities late in the fourth quarter of 2017 resulted in a loss on sale of investment securities of $7.6 million.

Total deposits were $13.64 billion at December 31, 2017, compared to $13.81 billion at September 30, 2017, and $12.87 billion at December 31, 2016. The decrease in deposits during the fourth quarter of 2017 was primarily due to a decline in interest-bearing demand deposits. The Corporation experienced net run-off in customer deposits of $163.1 million during the fourth quarter of 2017 primarily due to a seasonal decline in municipal deposits; however, the Corporation experienced net organic growth in customer deposits of $862.6 million for the year ended December 31, 2017.

Securities sold under agreements to repurchase with customers were $415.2 million at December 31, 2017, compared to $414.6 million at September 30, 2017, and $343.0 million at December 31, 2016. Short-term borrowings were $2.00 billion at December 31, 2017, compared to $1.90 billion at September 30, 2017, and $0.83 billion at December 31, 2016, and consisted of short-term FHLB advances utilized by the Corporation to fund short-term liquidity needs. Long-term borrowings were $372.9 million at December 31, 2017, compared to $397.8 million at September 30, 2017, and $597.8 million at December 31, 2016. The increase in short-term borrowings during the year ended December 31, 2017 was primarily utilized to fund loan growth and increase the investment securities portfolio.

The Corporation's shareholders' equity to total assets ratio was 13.8% at December 31, 2017, compared to 13.8% at September 30, 2017, and 14.9% at December 31, 2016. The Corporation's tangible shareholders' equity to assets ratio, a non-GAAP financial measure, and total risk-based capital ratio, were 8.3% and 10.9% (estimated), respectively, at December 31, 2017, compared to 8.3% and 11.2%, respectively, at September 30, 2017, and 8.8% and 11.5%, respectively, at December 31, 2016.(1) The Corporation's book value was $37.48 per share at December 31, 2017, compared to $37.57 per share at September 30, 2017 and $36.57 per share at December 31, 2016. The Corporation's tangible book value, a non-GAAP financial measure, was $21.21 per share at December 31, 2017, compared to $21.36 per share at September 30, 2017, and $20.20 per share at December 31, 2016.(1)

(1) Please refer to the section entitled "Non-GAAP Financial Measures" in this press release and to the financial tables entitled "Reconciliation of Non-GAAP Financial Measures" for a reconciliation to the most directly comparable GAAP financial measures.

Conference Call Details

Chemical Financial Corporation will host a conference call to discuss its fourth quarter and full year 2017 operating results on Wednesday, January 24, 2018 at 10:30 am ET. Anyone interested may access the conference call on a live basis by dialing toll-free at 1-888-523-1194 and entering 462654 for the conference ID. The call will also be broadcast live over the Internet hosted at Chemical Financial Corporation's website at www.chemicalbank.com under the "Investor Info" section. A copy of the slide-show presentation and an audio replay of the call will remain available on Chemical Financial Corporation's website for at least 14 days.

About Chemical Financial Corporation

Chemical Financial Corporation is the largest banking company headquartered and operating branch offices in Michigan. The Corporation operates through its subsidiary bank, Chemical Bank, with 212 banking offices located in Michigan, northeast Ohio and northern Indiana. At December 31, 2017, the Corporation had total assets of $19.28 billion. Chemical Financial Corporation's common stock trades on The NASDAQ Stock Market under the symbol CHFC and is one of the issuers comprising The NASDAQ Global Select Market and the S&P MidCap 400 Index. More information about the Corporation is available by visiting the "Investor Info" section of its website at www.chemicalbank.com.

Non-GAAP Financial Measures

This press release contains references to financial measures which are not defined in generally accepted accounting principles ("GAAP"). Such non-GAAP financial measures including measures that exclude significant items, net income, diluted earnings per share, return on average assets and return on average shareholders' equity, the Corporation's tangible equity to tangible assets ratio, tangible book value per share, presentation of net interest income and net interest margin on a fully taxable equivalent (FTE) basis, core operating expenses (which excludes merger and restructuring expenses and impairment of income tax credits), operating expenses-efficiency ratio (which excludes merger and restructuring expenses, impairment of federal historic tax credits and amortization of intangibles), and the adjusted efficiency ratio (which excludes significant items, impairment of federal historic tax credits, loan servicing rights change in fair value gains (losses), amortization of intangibles, net interest income FTE adjustments, (losses) gains from sale of investment securities and closed branch locations).

These non-GAAP financial measures have been included as the Corporation believes they are helpful for investors to analyze and evaluate the Corporation's financial condition. However, these non-GAAP financial measures have inherent limitations and should not be considered in isolation or as a substitute for GAAP measures. In addition, because non-GAAP measures are not standardized, it may not be possible to compare the non-GAAP historical measures in this press release with other companies non-GAAP financial measures. Reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measure may be found in the financial tables included with this press release.

Forward-Looking Statements

This press release contains forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates and projections about the financial services industry, the economy and the Corporation. Words and phrases such as "anticipates," "believes," "continue," "estimates," "expects," "forecasts," "future," "intends," "is likely," "judgment," "look ahead," "look forward," "on schedule," "opinion," "opportunity," "plans," "potential," "predicts," "probable," "projects," "should," "strategic," "trend," "will," and variations of such words and phrases or similar expressions are intended to identify such forward-looking statements. These statements include, among others, statements related to our belief that the efforts that we have undergone will put the Corporation in a solid position for a successful 2018, statements about growth in the Corporation's markets to be achieved through investments and expanding commercial lending and banking teams, and our expectations regarding operating expenses related to our restructuring efforts. All statements referencing future time periods are forward-looking.

Management's determination of the provision and allowance for loan losses; the carrying value of acquired loans, goodwill and mortgage servicing rights; the fair value of investment securities (including whether any impairment on any investment security is temporary or other-than-temporary and the amount of any impairment); and management's assumptions concerning pension and other postretirement benefit plans involve judgments that are inherently forward-looking. There can be no assurance that future loan losses will be limited to the amounts estimated. All of the information concerning interest rate sensitivity is forward-looking. The future effect of changes in the financial and credit markets and the national and regional economies on the banking industry, generally, and on the Corporation, specifically, are also inherently uncertain.

Forward-looking statements are based upon current beliefs and expectations and involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Accordingly, such statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions ("risk factors") that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statements. The Corporation undertakes no obligation to update, amend or clarify forward-looking statements, whether as a result of new information, future events or otherwise. Risk factors include, without limitation, a downturn in the economy, particularly in our markets, volatile credit and financial markets both domestic and foreign, potential deterioration in real estate value, regulatory changes, excessive loan losses, the Corporation's inability to attract and retain new commercial lenders and other bankers as well as key operations staff in light of competition for experienced employees in the banking industry, the Corporation's inability to execute on its strategy to expand investments and commercial lending, the Corporation's inability to grow its deposits while reducing the number of physical branches that is operates, and negative reactions to the restructuring efforts by Chemical Bank's customers, employees and other counterparties.

In addition, risk factors include, but are not limited to, the risk factors described in Item 1A of the Corporation's Annual Report on Form 10-K for the year ended December 31, 2016. These and other factors are representative of the risk factors that may emerge and could cause a difference between an ultimate actual outcome and a preceding forward-looking statement.


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Consolidated Statements of Financial Position (Unaudited)
Chemical Financial Corporation
(In thousands, except per share data)
December 31, 2017 September 30, 2017 December 31, 2016
Assets
Cash and cash equivalents:
Cash and cash due from banks $226,003 $223,498 $237,758
Interest-bearing deposits with the Federal Reserve Bank and other banks and federal funds sold 229,988 485,713 236,644
Total cash and cash equivalents 455,991 709,211 474,402
Investment securities:
Available-for-sale 1,963,546 2,029,672 1,234,964
Held-to-maturity 677,093 657,176 623,427
Total investment securities 2,640,639 2,686,848 1,858,391
Loans held-for-sale 52,133 87,198 81,830
Loans:
Total loans 14,155,267 13,833,368 12,990,779
Allowance for loan losses (91,887) (85,760) (78,268)
Net loans 14,063,380 13,747,608 12,912,511
Premises and equipment 126,896 141,550 145,012
Loan servicing rights 63,841 62,195 58,315
Goodwill 1,134,568 1,134,568 1,133,534
Other intangible assets 34,271 35,797 40,211
Interest receivable and other assets 709,154 749,333 650,973
Total Assets $19,280,873 $19,354,308 $17,355,179
Liabilities
Deposits:
Noninterest-bearing $3,725,779 $3,688,848 $3,341,520
Interest-bearing 9,917,024 10,116,397 9,531,602
Total deposits 13,642,803 13,805,245 12,873,122
Interest payable and other liabilities 181,203 163,532 134,637
Securities sold under agreements to repurchase with customers 415,236 414,597 343,047
Short-term borrowings 2,000,000 1,900,000 825,000
Long-term borrowings 372,882 397,845 597,847
Total liabilities 16,612,124 16,681,219 14,773,653
Shareholders' Equity
Preferred stock, no par value per share
Common stock, $1 par value per share 71,207 71,152 70,599
Additional paid-in capital 2,203,637 2,201,334 2,210,762
Retained earnings 414,885 425,433 340,201
Accumulated other comprehensive loss (20,980) (24,830) (40,036)
Total shareholders' equity 2,668,749 2,673,089 2,581,526
Total Liabilities and Shareholders' Equity $19,280,873 $19,354,308 $17,355,179


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Consolidated Statements of Income (Unaudited)
Chemical Financial Corporation
(In thousands, except per share data)
Three Months Ended Year Ended
December 31,
2017
September 30,
2017
December 31,
2016
December 31,
2017
December 31,
2016
Interest Income
Interest and fees on loans$150,558 $148,771 $134,463 $573,128 $383,545
Interest on investment securities:
Taxable10,289 9,326 4,687 31,496 10,989
Tax-exempt5,105 4,577 3,940 18,343 12,317
Dividends on nonmarketable equity securities2,018 1,039 582 4,924 1,973
Interest on deposits with the Federal Reserve Bank and other banks and federal funds sold1,192 1,231 744 4,244 1,555
Total interest income169,162 164,944 144,416 632,135 410,379
Interest Expense
Interest on deposits14,303 12,926 8,866 46,727 23,021
Interest on short-term borrowings7,413 6,591 875 20,321 1,660
Interest on long-term borrowings1,541 1,799 2,228 7,509 4,617
Total interest expense23,257 21,316 11,969 74,557 29,298
Net Interest Income145,905 143,628 132,447 557,578 381,081
Provision for loan losses7,522 5,499 6,272 23,300 14,875
Net interest income after provision for loan losses138,383 138,129 126,175 534,278 366,206
Noninterest Income
Service charges and fees on deposit accounts9,073 9,147 8,414 35,001 28,136
Wealth management revenue6,539 6,188 6,034 25,512 22,601
Other charges and fees for customer services7,522 6,624 9,981 32,771 30,246
Net gain on sale of loans and other mortgage banking revenue7,925 5,241 14,420 32,205 21,859
(Loss) gain on sale of investment securities(7,556) 1 76 (7,388) 129
Gain on sale of branches 7,391 7,391
Other8,816 4,921 7,948 25,918 11,988
Total noninterest income32,319 32,122 54,264 144,019 122,350
Operating Expenses
Salaries, wages and employee benefits48,358 52,621 57,631 213,828 165,213
Occupancy7,546 6,871 7,644 30,554 23,525
Equipment and software8,000 7,582 8,709 32,248 24,408
Outside processing and service fees9,081 9,626 7,290 35,142 21,199
Merger expenses1,511 2,379 18,016 8,522 61,134
Restructuring expenses1,056 18,824 19,880
Other24,470 21,636 15,012 81,820 42,939
Total operating expenses100,022 119,539 114,302 421,994 338,418
Income before income taxes70,680 50,712 66,137 256,303 150,138
Income tax expense61,234 10,253 18,969 106,780 42,106
Net Income$9,446 $40,459 $47,168 $149,523 $108,032
Earnings Per Common Share:
Weighted average common shares outstanding-basic71,095 70,911 70,171 70,865 49,091
Weighted average common shares outstanding-diluted71,682 71,505 71,304 71,513 49,603
Basic earnings per common share$0.13 $0.57 $0.67 $2.11 $2.21
Diluted earnings per common share$0.13 $0.56 $0.66 $2.08 $2.17
Diluted, excluding significant items (non-GAAP)$0.87 $0.76 $0.75 $3.06 $2.88
Cash Dividends Declared Per Common Share$0.28 $0.28 $0.27 $1.10 $1.06
Key Ratios (annualized where applicable):
Return on average assets0.20% 0.86% 1.09% 0.81% 0.90%
Return on average shareholders' equity1.4% 6.1% 7.4% 5.7% 7.0%
Return on average tangible shareholders' equity, excluding significant items (non-GAAP)16.5% 14.6% 15.3% 14.9% 14.9%
Net interest margin (tax-equivalent basis) (non-GAAP)3.47% 3.48% 3.56% 3.48% 3.60%
Efficiency ratio - GAAP56.1% 68.0% 61.2% 60.1% 67.2%
Efficiency ratio - adjusted (non-GAAP)47.4% 51.2% 53.7% 51.9% 54.4%


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Selected Quarterly Information (Unaudited)
Chemical Financial Corporation
(Dollars in thousands, except per share data)
4th Quarter 2017 3rd Quarter 2017 2nd Quarter 2017 1st Quarter 2017 4th Quarter 2016 3rd Quarter 2016 2nd Quarter 2016 1st Quarter 2016
Summary of Operations
Interest income$169,162 $164,944 $155,133 $142,896 $144,416 $103,562 $82,937 $79,464
Interest expense23,257 21,316 17,185 12,799 11,969 6,753 5,442 5,134
Net interest income145,905 143,628 137,948 130,097 132,447 96,809 77,495 74,330
Provision for loan losses7,522 5,499 6,229 4,050 6,272 4,103 3,000 1,500
Net interest income after provision for loan losses138,383 138,129 131,719 126,047 126,175 92,706 74,495 72,830
Noninterest income32,319 32,122 41,568 38,010 54,264 27,770 20,897 19,419
Operating expenses, excluding merger and restructuring expenses and impairment of income tax credits (non-GAAP)91,298 95,241 97,772 100,029 96,286 68,674 56,031 56,293
Merger and restructuring expenses2,567 21,203 465 4,167 18,016 37,470 3,054 2,594
Impairment of income tax credits6,157 3,095
Income before income taxes70,680 50,712 75,050 59,861 66,137 14,332 36,307 33,362
Income tax expense61,234 10,253 23,036 12,257 18,969 2,848 10,532 9,757
Net income$9,446 $40,459 $52,014 $47,604 $47,168 $11,484 $25,775 $23,605
Significant items, net of tax53,240 13,782 302 2,709 6,906 25,118 1,985 1,686
Net income, excluding significant items$62,686 $54,241 $52,316 $50,313 $54,074 $36,602 $27,760 $25,291
Per Common Share Data
Net income:
Basic$0.13 $0.57 $0.73 $0.67 $0.67 $0.23 $0.67 $0.61
Diluted0.13 0.56 0.73 0.67 0.66 0.23 0.67 0.60
Diluted, excluding significant items (non-GAAP)0.87 0.76 0.73 0.70 0.75 0.73 0.72 0.65
Cash dividends declared0.28 0.28 0.27 0.27 0.27 0.27 0.26 0.26
Book value - period-end37.48 37.57 37.11 36.56 36.57 36.37 27.45 26.99
Tangible book value - period-end21.21 21.36 20.89 20.32 20.20 19.99 19.68 19.20
Market value - period-end53.47 52.26 48.41 51.15 54.17 44.13 37.29 35.69
Net interest margin (taxable equivalent basis) (non-GAAP)3.47% 3.48% 3.48% 3.49% 3.56% 3.58% 3.70% 3.60%
Efficiency ratio - adjusted (non-GAAP)47.4% 51.2% 52.2% 57.4% 53.7% 52.7% 54.6% 57.6%
Return on average assets0.20% 0.86% 1.14% 1.09% 1.09% 0.37% 1.10% 1.02%
Return on average shareholders' equity1.4% 6.1% 8.0% 7.4% 7.4% 2.9% 10.0% 9.3%
Average shareholders' equity as a percent of average assets13.9% 14.0% 14.3% 14.8% 14.9% 12.7% 11.1% 11.0%
Capital ratios (period end):
Tangible shareholders' equity as a percent of tangible assets8.3% 8.3% 8.4% 8.8% 8.8% 8.7% 8.2% 8.2%
Total risk-based capital ratio (1)10.9% 11.2% 11.1% 11.4% 11.5% 11.1% 11.4% 11.5%
(1) Estimated at December 31, 2017.


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Average Balances, Tax Equivalent Interest and Effective Yields and Rates (Unaudited)(1)
Chemical Financial Corporation
(Dollars in thousands)
Three Months Ended
December 31, 2017 September 30, 2017 December 31, 2016
Average
Balance
Interest (FTE) Effective
Yield/Rate(1)
Average
Balance
Interest (FTE) Effective
Yield/Rate(1)
Average
Balance
Interest (FTE) Effective
Yield/Rate(1)
Assets
Interest-earning assets:
Loans(1)(2)$13,954,366 $151,413
4.31% $13,795,750 $149,595
4.31% $12,895,557 $135,301
4.18%
Taxable investment securities 1,715,494 10,289 2.40 1,629,344 9,326 2.29 1,065,453 4,687 1.76
Tax-exempt investment securities(1) 981,299 7,830 3.19 896,854 7,013 3.13 807,093 6,047 3.00
Other interest-earning assets 180,098 2,018 4.45 180,188 1,039 2.29 80,202 582 2.89
Interest-bearing deposits with the FRB and other banks and federal funds sold 307,028 1,192 1.54 313,104 1,231 1.56 307,802 744 0.96
Total interest-earning assets 17,138,285 172,742 4.01 16,815,240 168,204 3.98 15,156,107 147,361 3.87
Less: allowance for loan losses (86,521) (84,640) (74,822)
Other assets:
Cash and cash due from banks 239,307 250,743 245,613
Premises and equipment 138,880 146,266 144,652
Interest receivable and other assets 1,777,479 1,730,539 1,793,118
Total assets$19,207,430
$18,858,148 $17,264,668
Liabilities and shareholders' equity
Interest-bearing liabilities:
Interest-bearing demand deposits$2,709,033 $1,242 0.18% $2,725,807 $1,321 0.19% $2,680,241 $1,266 0.19%
Savings deposits 4,023,075 4,296 0.42 4,012,299 3,985 0.39 3,490,972 1,263 0.14
Time deposits 3,136,655 8,765 1.11 3,007,109 7,620 1.01 3,209,695 6,337 0.79
Short-term borrowings 2,366,571 7,413 1.24 2,279,998 6,591 1.15 949,292 875 0.38
Long-term borrowings 383,739 1,541 1.67 426,155 1,799 1.67 600,066 2,228 1.41
Total interest-bearing liabilities 12,619,073 23,257 0.73 12,451,368 21,316 0.68 10,930,266 11,969 0.44
Noninterest-bearing deposits 3,734,650 3,643,765 3,622,365
Total deposits and borrowed funds 16,353,723 23,257 0.56 16,095,133 21,316 0.53 14,552,631 11,969 0.33
Interest payable and other liabilities 177,678 119,782 147,094
Shareholders' equity 2,676,029 2,643,233 2,564,943
Total liabilities and shareholders' equity$19,207,430 $18,858,148 $17,264,668
Net Interest Spread (Average yield earned on interest-earning assets minus average rate paid on interest-bearing liabilities) 3.28% 3.30% 3.43%
Net Interest Income (FTE) $149,485 $146,888 $135,392
Net Interest Margin (Net Interest Income (FTE) divided by total average interest-earning assets) 3.47% 3.48% 3.56%
Reconciliation to Reported Net Interest Income
Net interest income, fully taxable equivalent (non-GAAP) $149,485
$146,888
$135,392
Adjustments for taxable equivalent interest(1):
Loans (855) (824) (838)
Tax-exempt investment securities (2,725) (2,436) (2,107)
Total taxable equivalent interest adjustments (3,580) (3,260) (2,945)
Net interest income (GAAP) $145,905
$143,628
$132,447
Net interest margin (GAAP) 3.39% 3.40% 3.48%

(1) Fully taxable equivalent (FTE) basis using a federal income tax rate of 35%. The presentation of net interest income on a FTE basis is not in accordance with GAAP, but is customary in the banking industry.
(2) Nonaccrual loans and loans held-for-sale are included in average balances reported and are included in the calculation of yields. Also, tax equivalent interest includes net loan fees.

Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Average Balances, Tax Equivalent Interest and Effective Yields and Rates (Unaudited)(1)
Chemical Financial Corporation
(Dollars in thousands)
Year Ended
December 31, 2017 December 31, 2016
Average
Balance
Interest (FTE) Effective
Yield/Rate(1)
Average
Balance
Interest (FTE) Effective
Yield/Rate(1)
Assets
Interest-earning assets:
Loans(1)(2) $13,607,683 $576,429 4.24% $9,304,573 $386,575 4.15%
Taxable investment securities 1,431,167 31,496 2.20 706,567 10,989 1.56
Tax-exempt investment securities(1) 905,831 28,120 3.10 595,677 18,929 3.18
Other interest-earning assets 157,738 4,924 3.12 55,341 1,973 3.57
Interest-bearing deposits with the FRB and other banks and federal funds sold 298,006 4,244 1.42 194,637 1,555 0.80
Total interest-earning assets 16,400,425 645,213 3.93 10,856,795 420,021 3.87
Less: allowance for loan losses (82,644) (73,136)
Other assets:
Cash and cash due from banks 235,621 186,706
Premises and equipment 144,114 118,080
Interest receivable and other assets 1,767,640 948,710
Total assets $18,465,156 $12,037,155
Liabilities and shareholders' equity
Interest-bearing liabilities:
Interest-bearing demand deposits $2,753,294 $4,870 0.18% $2,143,064 $3,277 0.15%
Savings deposits 3,940,499 13,049 0.33 2,534,038 2,877 0.11
Time deposits 3,014,302 28,808 0.96 2,154,118 16,867 0.78
Short-term borrowings 1,978,951 20,321 1.03 571,510 1,660 0.29
Long-term borrowings 455,246 7,509 1.67 418,636 4,617 1.10
Total interest-bearing liabilities 12,142,292 74,557 0.61 7,821,366 29,298 0.37
Noninterest-bearing deposits 3,547,271 2,566,342
Total deposits and borrowed funds 15,689,563 74,557 0.48 10,387,708 29,298 0.28
Interest payable and other liabilities 147,731 102,726
Shareholders' equity 2,627,862 1,546,721
Total liabilities and shareholders' equity $18,465,156 $12,037,155
Net Interest Spread (Average yield earned on interest-earning assets minus average rate paid on interest-bearing liabilities) 3.32% 3.50%
Net Interest Income (FTE) $570,656 $390,723
Net Interest Margin (Net Interest Income (FTE) divided by total average interest-earning assets) 3.48% 3.60%
Reconciliation to Reported Net Interest Income
Net interest income, fully taxable equivalent (non-GAAP) $570,656 $390,723
Adjustments for taxable equivalent interest(1):
Loans (3,301) (3,030)
Tax-exempt investment securities (9,777) (6,612)
Total taxable equivalent interest adjustments (13,078) (9,642)
Net interest income (GAAP) $557,578 $381,081
Net interest margin (GAAP) 3.40% 3.51%
(1) Fully taxable equivalent (FTE) basis using a federal income tax rate of 35%. The presentation of net interest income on a FTE basis is not in accordance with GAAP, but is customary in the banking industry.
(2) Nonaccrual loans and loans held-for-sale are included in average balances reported and are included in the calculation of yields. Also, tax equivalent interest includes net loan fees.


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Noninterest Income and Operating Expenses Information (Unaudited)
Chemical Financial Corporation
(Dollars in thousands)
4th Quarter 2017 3rd Quarter 2017 2nd Quarter 2017 1st Quarter 2017 4th Quarter 2016 3rd Quarter 2016 2nd Quarter 2016 1st Quarter 2016
Noninterest income
Service charges and fees on deposit accounts$9,073 $9,147 $8,777 $8,004 $8,414 $7,665 $6,337 $5,720
Wealth management revenue6,539 6,188 6,958 5,827 6,034 5,584 5,782 5,201
Electronic banking fees5,578 4,370 7,482 6,817 8,196 5,533 4,786 4,918
Net gain on sale of loans and other mortgage banking revenue7,938 9,282 11,681 9,679 8,072 5,675 1,595 1,405
Change in fair value in loan servicing rights(1)(13) (4,041) (1,802) (519) 6,348 (1,236)
Other fees for customer services1,944 2,254 2,252 2,074 1,785 1,877 1,677 1,474
(Loss) gain on sale of investment securities(7,556) 1 77 90 76 16 18 19
Bank-owned life insurance1,377 1,124 1,106 1,211 957 446 237 196
Gain on sale of branch offices 7,391
Other7,439 3,797 5,037 4,827 6,991 2,210 465 486
Total noninterest income$32,319 $32,122 $41,568 $38,010 $54,264 $27,770 $20,897 $19,419
(1) Included within the line item "Net gain on sale of loans and other mortgage banking revenue" in the Consolidated Statements of Income.


4th Quarter 2017 3rd Quarter 2017 2nd Quarter 2017 1st Quarter 2017 4th Quarter 2016 3rd Quarter 2016 2nd Quarter 2016 1st Quarter 2016
Operating expenses
Salaries and wages$41,866 $44,641 $44,959 $48,526 $47,936 $33,841 $26,887 $26,743
Employee benefits6,492 7,980 7,642 11,722 9,695 6,724 6,240 7,147
Occupancy7,546 6,871 8,745 7,392 7,644 5,462 5,514 4,905
Equipment and software8,000 7,582 8,149 8,517 8,709 6,420 4,875 4,404
Outside processing and service fees9,081 9,626 8,924 7,511 7,290 5,365 4,833 3,711
FDIC insurance premiums4,556 2,768 2,460 1,406 2,813 1,849 1,338 1,407
Professional fees3,483 3,489 2,567 1,968 2,304 1,472 1,020 1,036
Intangible asset amortization1,525 1,526 1,525 1,513 1,843 1,292 1,195 1,194
Credit-related expenses803 1,874 1,895 1,200 (1,029) (371) (1,331) 30
Merger expenses1,511 2,379 465 4,167 18,016 37,470 3,054 2,594
Restructuring expenses1,056 18,824
Impairment of income tax credit6,157 3,095
Other7,946 8,884 10,906 10,274 9,081 6,620 5,460 5,716
Total operating expenses$100,022 $119,539 $98,237 $104,196 $114,302 $106,144 $59,085 $58,887


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Composition of Loans and Deposits and Additional Information on Intangible Assets (Unaudited)
Chemical Financial Corporation
(Dollars in Thousands)
Dec 31,
2017
Sep 30,
2017
Organic
Growth -
Three
Months
Ended
Dec 31,
2017
Jun 30,
2017
Mar 31,
2017
Dec 31,
2016
Organic
Growth -
Twelve
Months
Ended
Dec 31,
2017
Composition of Loans
Commercial loan portfolio:
Commercial$3,385,642 $3,319,965 2.0% $3,360,161 $3,253,608 $3,217,300 5.2%
Commercial real estate4,500,670 4,315,978 4.3 4,324,323 4,097,771 3,973,140 13.3
Real estate construction574,215 501,413 14.5 446,678 453,811 403,772 42.2
Subtotal - commercial loans8,460,527 8,137,356 4.0 8,131,162 7,805,190 7,594,212 11.4
Consumer loan portfolio:
Residential mortgage3,252,487 3,221,307 1.0 3,125,397 3,133,465 3,086,474 5.4
Consumer installment1,613,008 1,615,983 (0.2) 1,553,967 1,481,057 1,433,884 12.5
Home equity829,245 858,722 (3.4) 856,846 853,680 876,209 (5.4)
Subtotal - consumer loans5,694,740 5,696,012 5,536,210 5,468,202 5,396,567 5.5
Total loans$14,155,267 $13,833,368 2.3% $13,667,372 $13,273,392 $12,990,779 9.0%


Dec 31,
2017
Sep 30,
2017
Organic
Growth -
Three
Months
Ended
Dec 31,
2017
Jun 30,
2017
Mar 31,
2017
Dec 31,
2016
Organic
Growth -
Twelve
Months
Ended
Dec 31,
2017
Composition of Deposits
Noninterest-bearing demand$3,725,779 $3,688,848 1.0% $3,399,287 $3,341,520 $3,341,520 11.5%
Savings1,697,762 1,736,360 (2.2) 1,752,040 1,662,115 1,662,115 2.1
Interest-bearing demand2,725,336 2,976,212 (8.4) 2,900,546 2,825,801 2,825,801 (3.6)
Money market accounts2,276,719 2,289,852 (0.6) 2,161,645 2,033,319 2,033,319 12.0
Brokered deposits133,496 132,806 0.5 156,367 226,429 226,429 (41.0)
Other time deposits3,083,711 2,981,167 3.4 2,762,462 2,783,938 2,783,938 10.8
Total deposits$13,642,803 $13,805,245 (1.2)% $13,132,347 $12,873,122 $12,873,122 6.0%


Dec 31,
2017
Sep 30,
2017
Jun 30,
2017
Mar 31,
2017
Dec 31,
2016
Additional Data - Intangibles
Goodwill$1,134,568 $1,134,568 $1,133,534 $1,133,534 $1,133,534
Loan servicing rights63,841 62,195 64,522 64,604 58,315
Core deposit intangibles (CDI)34,259 35,747 37,235 38,723 40,211
Noncompete agreements13 50 87 125


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Nonperforming Assets (Unaudited)
Chemical Financial Corporation
(Dollars in thousands)
Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016
Nonperforming Assets
Nonperforming Loans(1):
Nonaccrual loans:
Commercial $19,691 $15,648 $18,773 $16,717 $13,178 $13,742 $14,577 $19,264
Commercial real estate 29,545 25,150 19,723 20,828 19,877 19,914 21,325 25,859
Real estate construction 77 78 56 79 80 80 496 546
Residential mortgage 8,635 8,646 7,714 6,749 6,969 5,119 5,343 5,062
Consumer installment 842 875 757 755 879 378 285 360
Home equity 4,305 3,908 3,871 2,713 3,351 2,064 1,971 2,328
Total nonaccrual loans(1) 63,095 54,305 50,894 47,841 44,334 41,297 43,997 53,419
Other real estate and repossessed assets 8,807 10,605 14,582 16,395 17,187 20,730 8,440 9,248
Total nonperforming assets $71,902 $64,910 $65,476 $64,236 $61,521 $62,027 $52,437 $62,667
Accruing loans contractually past due 90 days or more as to interest or principal payments, excluding acquired loans accounted for under ASC 310-30:
Commercial $ $3,521 $58 $1,823 $11 $221 $3 $370
Commercial real estate 13 144 262 700 277 739 3
Real estate construction 1,439
Residential mortgage 375 407 423
Home equity 1,364 2,367 2,026 1,169 995 628 1,071 679
Total accruing loans contractually past due 90 days or more as to interest or principal payments $1,377 $6,032 $2,346 $3,692 $1,283 $3,402 $1,484 $1,472
(1) Acquired loans, accounted for under Accounting Standards Codification 310-30, that are not performing in accordance with contractual terms are not reported as nonperforming loans because these loans are recorded in pools at their net realizable value based on the principal and interest the Corporation expects to collect on these loans.


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Summary of Loan Loss Experience (Unaudited)
Chemical Financial Corporation
(Dollars in thousands)
Year Ended
4th Quarter 2017 3rd Quarter 2017 2nd Quarter 2017 1st Quarter 2017 4th Quarter 2016 3rd Quarter 2016 2nd Quarter 2016 1st Quarter 2016 Dec 31,
2017
Dec 31,
2016
Allowance for loan losses - originated portfolio
Allowance for loan losses - beginning of period$85,181 $83,797 $78,774 $78,268 $73,775 $71,506 $70,318 $73,328 $78,268 $73,328
Provision for loan losses8,101 4,920 6,229 4,050 6,272 4,103 3,000 1,500 23,300 14,875
Net loan charge-offs:
Commercial(613) (2,348) (239) (1,999) (336) (150) (1,153) (3,115) (5,199) (4,754)
Commercial real estate783 (174) (205) 730 (280) (154) (187) (440) 1,134 (1,061)
Real estate construction(1) (9) 36 (31) (11) (10) (6)
Residential mortgage(142) (44) 19 (567) (236) (304) 8 (172) (734) (704)
Consumer installment(1,318) (857) (747) (1,310) (823) (1,137) (486) (602) (4,232) (3,048)
Home equity(104) (113) (34) (389) (140) (58) 6 (170) (640) (362)
Net loan charge-offs(1,395) (3,536) (1,206) (3,544) (1,779) (1,834) (1,812) (4,510) (9,681) (9,935)
Allowance for loan losses - end of period$91,887 $85,181 $83,797 $78,774 $78,268 $73,775 $71,506 $70,318 $91,887 $78,268
Allowance for loan losses - acquired loan portfolio
Allowance for loan losses - beginning of period579
Provision for loan losses(579) 579
Allowance for loan losses - end of period 579
Total allowance for loan losses$91,887 $85,760 $83,797 $78,774 $78,268 $73,775 $71,506 $70,318 $91,887 $78,268
Net loan charge-offs as a percent of average loans (quarterly amounts annualized)0.04% 0.10% 0.04% 0.11% 0.06% 0.08% 0.10% 0.25% 0.07% 0.11%


Dec 31,
2017
Sep 30,
2017
Jun 30,
2017
Mar 31,
2017
Dec 31,
2016
Originated loans$9,747,429 $9,156,096 $8,659,622 $7,959,769 $7,458,401
Acquired loans4,407,838 4,677,272 5,007,750 5,313,623 5,532,378
Total loans$14,155,267 $13,833,368 $13,667,372 $13,273,392 $12,990,779
Allowance for loan losses as a percent of:
Total originated loans0.94% 0.93% 0.97% 0.99% 1.05%
Nonperforming loans145.6% 156.9% 164.7% 177.7% 176.5%
Credit mark as a percent of unpaid principal balance on acquired loans2.4% 2.7% 2.6% 2.8% 3.1%


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Reconciliation of Non-GAAP Financial Measures (Unaudited)
Chemical Financial Corporation
(Dollars in thousands)
4th Quarter 2017 3rd Quarter 2017 2nd Quarter 2017 1st Quarter 2017 4th Quarter 2016 3rd Quarter 2016 2nd Quarter 2016 1st Quarter 2016 Year Ended
Dec 31, 2017 Dec 31, 2016
Non-GAAP Operating Results
Net Income
Net income, as reported$9,446 $40,459
$52,014
$47,604
$47,168
$11,484
$25,775
$23,605
$149,523
$108,032
Merger and restructuring expenses 2,567 21,203 465 4,167 18,016 37,470 3,054 2,594 28,402 61,134
Gain on sales of branch offices (7,391) (7,391)
Losses on sales of investment securities(1) 7,556 7,556
Significant items 10,123 21,203 465 4,167 10,625 37,470 3,054 2,594 35,958 53,743
Income tax benefit (2) (3,543) (7,421) (163) (1,458) (3,719) (12,352) (1,069) (908) (12,585) (18,048)
Revaluation of net deferred tax assets 46,660 46,660
Significant items, net of tax 53,240 13,782 302 2,709 6,906 25,118 1,985 1,686 70,033 35,695
Net income, excluding significant items$62,686 $54,241 $52,316 $50,313 $54,074 $36,602 $27,760 $25,291 $219,556 $143,727
Diluted Earnings Per Share
Diluted earnings per share, as reported$0.13 $0.56 $0.73 $0.67 $0.66 $0.23 $0.67 $0.60 $2.08 $2.17
Effect of significant items, net of tax 0.74 0.20 0.03 0.09 0.50 0.05 0.05 0.98 0.71
Diluted earnings per share, excluding significant items$0.87 $0.76 $0.73 $0.70 $0.75 $0.73 $0.72 $0.65 $3.06 $2.88
Return on Average Assets
Return on average assets, as reported 0.20% 0.86% 1.14% 1.09% 1.09% 0.37% 1.10% 1.02% 0.81% 0.90%
Effect of significant items, net of tax 1.11 0.29 0.01 0.06 0.16 0.83 0.09 0.07 0.38 0.29
Return on average assets, excluding significant items 1.31% 1.15% 1.15% 1.15% 1.25% 1.20% 1.19% 1.09% 1.19% 1.19%
Return on Average Shareholders' Equity
Return on average shareholders' equity, as reported 1.4% 6.1% 8.0% 7.4% 7.4% 2.9% 10.0% 9.3% 5.7% 7.0%
Effect of significant items, net of tax 8.0 2.1 0.4 1.0 6.5 0.7 0.6 2.7 2.3
Return on average shareholders' equity, excluding significant items 9.4% 8.2% 8.0% 7.8% 8.4% 9.4% 10.7% 9.9% 8.4% 9.3%
Return on Average Tangible Shareholders' Equity
Average shareholders' equity, as reported$2,676,029
$2,643,233
$2,606,517
$2,584,501
$2,564,943
$1,559,668
$1,033,014
$1,017,929
$2,627,862
$1,546,721
Average goodwill, CDI and noncompete agreements, net of tax 1,156,122
1,153,394
1,154,229
1,155,177
1,153,598
585,393
295,882
299,685
1,155,734
582,536
Average tangible shareholders' equity 1,519,907
1,489,839
1,452,288
1,429,324
1,411,345
974,275
737,132
718,244
1,472,128
964,185
Return on average tangible shareholders' equity 2.5% 10.9% 14.3% 13.3% 13.4% 4.7% 14.0% 13.1% 10.2% 11.2%
Effect of significant items, net of tax 14.0 3.7 0.1 0.8 1.9 10.3 1.1 1.0 4.7 3.7
Return on average tangible shareholders' equity, excluding significant items 16.5% 14.6% 14.4% 14.1% 15.3% 15.0% 15.1% 14.1% 14.9% 14.9%
(1) Represents losses on sales of investment securities in the fourth quarter of 2017 as part of the Corporation's treasury and tax management objectives.

(2) Assumes transaction expenses and other significant items are deductible at an income tax rate of 35%, except for the impact of estimated nondeductible expenses incurred in periods when the Corporation completes merger and acquisition transactions.


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Reconciliation of Non-GAAP Financial Measures (Unaudited)
Chemical Financial Corporation
(Dollars in thousands, except per share data)
4th Quarter 2017 3rd Quarter 2017 2nd Quarter 2017 1st Quarter 2017 4th Quarter 2016 3rd Quarter 2016 2nd Quarter 2016 1st Quarter 2016 Year Ended
Dec 31, 2017 Dec 31, 2016
Efficiency Ratio
Net interest income$145,905 $143,628 $137,948 $130,097 $132,447 $96,809 $77,495 $74,330 $557,578 $381,081
Noninterest income32,319 32,122 41,568 38,010 54,264 27,770 20,897 19,419 144,019 122,350
Total revenue - GAAP178,224 175,750 179,516 168,107 186,711 124,579 98,392 93,749 701,597 503,431
Net interest income FTE adjustment3,580 3,260 3,169 3,068 2,945 2,426 2,138 2,133 13,077 9,642
Loan servicing rights change in fair value (gains)losses13 4,041 1,802 519 (6,348) 1,236 6,375 (5,112)
Gains on sales of branches (7,391) (7,391)
Losses (gains) from sale of investment securities and closed branch locations7,556 (1) (77) (90) (76) (301) (123) (169) 7,388 (669)
Total revenue - Non-GAAP$189,373 $183,050 $184,410 $171,604 $175,841 $127,940 $100,407 $95,713 $728,437 $499,901
Operating expenses - GAAP$100,022 $119,539 $98,237 $104,196 $114,302 $106,144 $59,085 $58,887 $421,994 $338,418
Merger and restructuring expenses(2,567) (21,203) (465) (4,167) (18,016) (37,470) (3,054) (2,594) (28,402) (61,134)
Impairment of income tax credits(6,157) (3,095) (9,252)
Operating expense, core - Non-GAAP91,298 95,241 97,772 100,029 96,286 68,674 56,031 56,293 384,340 277,284
Amortization of intangibles(1,525) (1,526) (1,525) (1,513) (1,843) (1,292) (1,195) (1,194) (6,089) (5,524)
Operating expenses, efficiency ratio - Non-GAAP$89,773 $93,715 $96,247 $98,516 $94,443 $67,382 $54,836 $55,099 $378,251 $271,760
Efficiency ratio - GAAP56.1% 68.0% 54.7% 62.0% 61.2% 85.2% 60.1% 62.8% 60.1% 67.2%
Efficiency ratio - adjusted Non-GAAP47.4% 51.2% 52.2% 57.4% 53.7% 52.7% 54.6% 57.6% 51.9% 54.4%


Chemical Financial Corporation Announces Fourth Quarter and Full Year 2017 Operating Results
Reconciliation of Non-GAAP Financial Measures (Unaudited)
Chemical Financial Corporation
(Dollars in thousands, except per share data)
Dec 31,
2017
Sep 30,
2017
Jun 30,
2017
Mar 31,
2017
Dec 31,
2016
Sep 30,
2016
Jun 30,
2016
Mar 31,
2016
Tangible Book Value
Shareholders' equity, as reported$2,668,749 $2,673,089 $2,639,442 $2,600,051 $2,581,526 $2,563,666 $1,050,299 $1,032,291
Goodwill, CDI and noncompete agreements, net of tax (1,158,738) (1,153,576) (1,153,595) (1,154,915) (1,155,528) (1,154,121) (297,044) (297,821)
Tangible shareholders' equity$1,510,011 $1,519,513 $1,485,847 $1,445,136 $1,425,998 $1,409,545 $753,255 $734,470
Common shares outstanding 71,207 71,152 71,131 71,118 70,599 70,497 38,267 38,248
Book value per share (shareholders' equity, as reported, divided by common shares outstanding)$37.48 $37.57 $37.11 $36.56 $36.57 $36.37 $27.45 $26.99
Tangible book value per share (tangible shareholders' equity divided by common shares outstanding)$21.21 $21.36 $20.89 $20.32 $20.20 $19.99 $19.68 $19.20
Tangible Shareholders' Equity to Tangible Assets
Total assets, as reported$19,280,873
$19,354,308
$18,781,405
$17,636,973
$17,355,179
$17,383,637
$9,514,172
$9,303,632
Goodwill, CDI and noncompete agreements, net of tax (1,158,738) (1,153,576) (1,153,595) (1,154,915) (1,155,528) (1,154,121) (297,044) (297,821)
Tangible assets$18,122,135
$18,200,732
$17,627,810
$16,482,058
$16,199,651
$16,229,516
$9,217,128
$9,005,811
Shareholders' equity to total assets 13.8% 13.8% 14.1% 14.7% 14.9% 14.7% 11.0% 11.1%
Tangible shareholders' equity to tangible assets 8.3% 8.3% 8.4% 8.8% 8.8% 8.7% 8.2% 8.2%

For further information:
David T. Provost, CEO
Dennis L. Klaeser, CFO
989-839-5350

Source:Chemical Financial Corporation